Moshe Elkabets

5PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 24, 2025
HLA-E[pHLA-G] complex-specific monoclonal antibody enhancing NK activity in multiple myeloma.

Muhammad Abu Ahmad, Olga Radinsky, Bar Kaufman

|Apr 17, 2025
Enhancing the Efficacy of CAR-T Cell Production Using BX795 and Rosuvastatin in a Serum-Free Medium.

Abed Al-Kader Yassin, Rajashri Banerji, Baisali Bhattacharya

|Jun 03, 2024
PD1 ligand functionality a biomarker of response to anti PD1 treatment in patients with HNSCC.

Bar Kaufman, Tarek Taha, Orli Abramov

|May 23, 2024
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer.

Thomas F Cyberski, Alka Singh, Michael Korzinkin

|May 26, 2023
Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer.

Bar Kaufman, Orli Abramov, Anna Ievko

Pageof 1